| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000023374 |
| Receipt No. | R000026932 |
| Official scientific title of the study | Neural basis for Cognitive Bias Modification for Interpretation |
| Date of disclosure of the study information | 2016/08/01 |
| Last modified on | 2016/07/28 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Neural basis for Cognitive Bias Modification for Interpretation | |
| Title of the study (Brief title) | Neural basis for Cognitive Bias Modification for Interpretation | |
| Region |
|
|
| Condition | ||
| Condition | none | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Understanding neural basis for cognitive bias modification for interpretation |
| Basic objectives2 | Others |
| Basic objectives -Others | Basic natural science |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Regional brain activity changes correlated to increase of positive interpretation of ambiguous social situations |
| Key secondary outcomes | Social anxiety, Depression, Personality traits |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | Imagining ambiguous social scenarios followed positive outcome, ~1 hour/day, 4 days/2 weeks | |
| Interventions/Control_2 | Imagining consistently positive social scenarios, ~1 hour/day, 4 days/2 weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healthy university students, Social anxiety tendency (More than 17 points of Fear of Negative Evaluation Scale) | |||
| Key exclusion criteria | MRI contraindication
Auditory inability left handedness Past history of neurological illness |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Ryuta Kawashima |
| Organization | Tohoku University |
| Division name | Institute of Development, Aging and Cancer |
| Address | Seiryo-machi 4-1, Aoba-ku, Sendai 980-8575 |
| TEL | 022-717-7988 |
| fbi@idac.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Kohei Sakaki |
| Organization | Tohoku University |
| Division name | Graduate School of Medicine |
| Address | Seiryo-machi 2-1, Aoba-ku, Sendai 980-8575 |
| TEL | 022-717-8585 |
| Homepage URL | |
| kohei.sakaki.q1@dc.tohoku.ac.jp | |
| Sponsor | |
| Institute | Institute of Development, Aging and Cancer, Tohoku University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Tohoku University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026932 |